OSIA
VIVO

O'Shares Investment Advisers’s Meridian Bioscience Inc VIVO Stock Holding History

O'Shares Investment Advisers’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,973
Closed -$320K – 418
2019
Q2 		$320K Sell
26,973
-380
-1% -$4.58K 0.05% 275
2019
Q1 		$482K Sell
27,353
-3,085
-10% -$51.3K 0.08% 218
2018
Q4 		$528K Buy
+30,438
New +$519K 0.1% 201

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

O'Shares Investment Advisers's VIVO Position: Q3 2019 in Review

O'Shares Investment Advisers sold out of Meridian Bioscience Inc (VIVO) in Q3 2019, closing a stake of 26,973 shares — an estimated $320K sold.

O'Shares Investment Advisers first reported a position in VIVO in Q4 2018 and held it in 3 quarters. The position peaked at $528K in Q4 2018. 163 funds tracked by Wall St. Rank hold VIVO as of Q3 2019.

  • O'Shares Investment Advisers reported no remaining Meridian Bioscience Inc position as of Q3 2019 after selling out during the quarter.
  • O'Shares Investment Advisers sold 26,973 Meridian Bioscience Inc shares in Q3 2019, an estimated $320K.
  • O'Shares Investment Advisers first reported a position in Meridian Bioscience Inc in Q4 2018 and held it in 3 quarters.
  • O'Shares Investment Advisers's Meridian Bioscience Inc position peaked at $528K in Q4 2018.
  • 163 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2019.

Based on O'Shares Investment Advisers's 13F filing for Q3 2019, filed 12 Nov 2019.